Iron Sucrose Supplement — Competitive Intelligence Brief

Iron Sucrose Supplement (Iron Sucrose Supplement) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iron supplement. Area: Hematology.

marketed Iron supplement Hematology Small molecule

Target snapshot

Iron Sucrose Supplement (Iron Sucrose Supplement) — Papageorgiou General Hospital. Iron sucrose provides bioavailable iron that is absorbed and incorporated into hemoglobin and other iron-dependent proteins to treat iron deficiency.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Iron Sucrose Supplement TARGET	Iron Sucrose Supplement	Papageorgiou General Hospital	marketed	Iron supplement
Ferric Pyrophosphate Liposomal	Ferric Pyrophosphate Liposomal	All India Institute of Medical Sciences	marketed	Iron supplement
Iron supplement C	Iron supplement C	Tanabe Pharma Corporation	marketed	Iron supplement	Iron (Fe2+/Fe3+)
Intravenous iron supplementation	Intravenous iron supplementation	University of Pecs	marketed	Iron supplement	Iron (Fe2+/Fe3+) for hemoglobin and myoglobin synthesis
Weekly Ferrous Sulfate	Weekly Ferrous Sulfate	Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri	marketed	Iron supplement	Iron (Fe2+) for hemoglobin synthesis
Orifer F®	Orifer F®	The Hospital for Sick Children	marketed	Iron supplement with folic acid
Fisiogen Ferro Forte	Fisiogen Ferro Forte	Hospital Universitari Vall d'Hebron Research Institute	marketed	Iron supplement	Iron (Fe2+/Fe3+)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iron supplement class)

1. Tanabe Pharma Corporation · 4 drugs in this class
2. Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri · 2 drugs in this class
3. Universidade Federal Fluminense · 2 drugs in this class
4. Clinica Fabia Mater · 1 drug in this class
5. GlaxoSmithKline · 1 drug in this class
6. Hatem AbuHashim · 1 drug in this class
7. Hospital Universitari Vall d'Hebron Research Institute · 1 drug in this class
8. Laboratoire Innotech International · 1 drug in this class
9. Lee's Pharmaceutical Limited · 1 drug in this class
10. Milton S. Hershey Medical Center · 1 drug in this class